USP9YP6

Q-omics provides the consensus-scored USP9YP6 profile across patient tissues and cancer cell-line models. USP9YP6 expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in LGG. Additionally, USP9YP6 RNA expression shows 466 significant mutation-linked associations, with the highest sampling consensus in STAD. Together, these results highlight LGG, and STAD as cancer lineages where USP9YP6 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes USP9YP6 survival associations across molecular data types. USP9YP6 RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

USP9YP6 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	ESCA (27)	view →

This table ranks reproducible USP9YP6 RNA expression–survival associations across cancer types. High USP9YP6 expression shows unfavorable associations in LGG and ESCA. The LGG Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LGG as the clearest survival context for USP9YP6 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Tertile	All	0.220	0.739	<.001	27	view →
ESCA	OS	Tertile	II,III,IV	0.415	0.707	.002	27	view →

Pink = unfavorable, green = favorable. all 2 lineages →

USP9YP6-LGG (DFS)

Explore this curve interactively →